Structural Basis for the Inhibition of Histone Deacetylase 8 (HDAC8), a Key Epigenetic Player in the Blood Fluke Schistosoma mansoni
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structural Basis for the Inhibition of Histone Deacetylase 8 (HDAC8), a Key Epigenetic Player in the Blood Fluke Schistosoma mansoni
Authors
Keywords
Schistosoma, Parasitic diseases, Schistosoma mansoni, Enzyme structure, Phenylalanine, Zinc, Enzyme inhibitors, Epigenetics
Journal
PLoS Pathogens
Volume 9, Issue 9, Pages e1003645
Publisher
Public Library of Science (PLoS)
Online
2013-09-27
DOI
10.1371/journal.ppat.1003645
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chromatin regulation in schistosomes and histone modifying enzymes as drug targets
- (2014) Raymond John Pierce et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Schistosomiasis
- (2013) C. Conlon et al. CLINICAL MEDICINE
- The genomes of four tapeworm species reveal adaptations to parasitism
- (2013) Isheng J. Tsai et al. NATURE
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- Design, Synthesis, and Biological Evaluation of 2-Aminobenzanilide Derivatives as Potent and Selective HDAC Inhibitors
- (2012) Diana A. Stolfa et al. ChemMedChem
- Decitabine for acute myeloid leukemia
- (2012) Peter W Marks Expert Review of Anticancer Therapy
- HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle
- (2012) Matthew A. Deardorff et al. NATURE
- Epigenetic protein families: a new frontier for drug discovery
- (2012) Cheryl H. Arrowsmith et al. NATURE REVIEWS DRUG DISCOVERY
- Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancer
- (2012) Missak Haigentz et al. ORAL ONCOLOGY
- Romidepsin: A Guide to its Clinical Use in Cutaneous T-Cell Lymphoma
- (2011) Katherine A. Lyseng-Williamson et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Cancer Chemoprevention by Targeting the Epigenome
- (2011) Joseph Huang et al. CURRENT DRUG TARGETS
- Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes
- (2011) Patrick M Lombardi et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- HDAC inhibitors in parasitic diseases
- (2011) Katherine T Andrews et al. IMMUNOLOGY AND CELL BIOLOGY
- Deciphering correct strategies for multiprotein complex assembly by co-expression: Application to complexes as large as the histone octamer
- (2011) Marie-Laure Diebold et al. JOURNAL OF STRUCTURAL BIOLOGY
- Targeting the epigenome for treatment of cancer
- (2011) E-J Geutjes et al. ONCOGENE
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Genetic Consequences of Mass Human Chemotherapy for Schistosoma mansoni: Population Structure Pre- and Post-Praziquantel Treatment in Tanzania
- (2010) Alice J. Norton et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Antimalarial histone deacetylase inhibitors containing cinnamate or NSAID components
- (2010) Nicole C. Wheatley et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides
- (2010) Jerome C. Bressi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Praziquantel and Schistosomiasis
- (2010) Alexander Dömling et al. ChemMedChem
- Epigenetic modifications as therapeutic targets
- (2010) Theresa K Kelly et al. NATURE BIOTECHNOLOGY
- Chemical phylogenetics of histone deacetylases
- (2010) James E Bradner et al. Nature Chemical Biology
- “Manifesto” for Advancing the Control and Elimination of Neglected Tropical Diseases
- (2010) Peter J. Hotez et al. PLoS Neglected Tropical Diseases
- Parasites and poverty: The case of schistosomiasis
- (2009) Charles H. King ACTA TROPICA
- Jalview Version 2--a multiple sequence alignment editor and analysis workbench
- (2009) A. M. Waterhouse et al. BIOINFORMATICS
- Histone Deacetylase Inhibitors in Cancer Therapy
- (2009) Andrew A. Lane et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification and Characterization of Small Molecule Inhibitors of a Class I Histone Deacetylase fromPlasmodium falciparum
- (2009) Vishal Patel et al. JOURNAL OF MEDICINAL CHEMISTRY
- Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni
- (2009) Florence Dubois et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- Helminths and malignancy
- (2009) B. J. VENNERVALD et al. PARASITE IMMUNOLOGY
- Potent Antimalarial Activity of Histone Deacetylase Inhibitor Analogues
- (2008) K. T. Andrews et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The class I histone deacetylases of the platyhelminth parasite Schistosoma mansoni
- (2008) Frédérik Oger et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Structural insights into the Plasmodium falciparum histone deacetylase 1 (PfHDAC-1): A novel target for the development of antimalarial therapy
- (2008) Prasenjit Mukherjee et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Pyridylalanine-Containing Hydroxamic Acids as Selective HDAC6 Inhibitors
- (2008) Stefan Schäfer et al. ChemMedChem
- Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis
- (2008) Michael J Doenhoff et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Human HDAC7 Harbors a Class IIa Histone Deacetylase-specific Zinc Binding Motif and Cryptic Deacetylase Activity
- (2008) Anja Schuetz et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas
- (2008) S Balasubramanian et al. LEUKEMIA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started